pharma.markets

  • HOME
  • Imprint

pfizer

Statement regarding European Commission’s Proposal to Purchase Additional Doses of BioNTech-Pfizer Vaccine

08/01/2021 MaP 0

We are in talks with the European Commission (EC) about an amendment to our existing supply agreement for COMIRNATY®, the Pfizer-BioNTech COVID-19 Vaccine. The amendment […]

An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation

08/01/2021 MaP 0

Associated with Rapid Transmission Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced results from an in vitro study conducted by Pfizer and […]

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®

29/12/2020 MaP 0

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY®, the companies’ COVID-19 Vaccine, […]

Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine COMIRNATY

21/12/2020 MaP 0

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the European Commission (EC) has granted a conditional marketing authorization (CMA) to Pfizer […]

Pfizer and BioNTech Provide Data from German Phase 1/2 Study Further Characterizing Immune Response Following Immunization with Lead COVID-19 Vaccine Candidate BNT162b2

14/12/2020 MaP 0

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced additional data on neutralizing antibody and T cell responses from the Phase 1/2 trial […]

Pfizer and BioNTech Vaccine to Prevent COVID-19 IMPORTANT SAFETY INFORMATION

12/12/2020 MaP 0

Do not administer Pfizer‑BioNTech COVID-19 Vaccine to individuals with known history of a severe allergic reaction (e.g., anaphylaxis) to any component of the Pfizer‑BioNTech COVID-19 […]

Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.

11/12/2020 MaP 0

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory […]

Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine

10/12/2020 MaP 0

Data from 43,448 participants, half of whom received BNT162b2 and half of whom received placebo, showed that the vaccine candidate was well tolerated and demonstrated […]

Pfizer and BioNTech Achieve Health Canada Authorization for Their Vaccine to Combat COVID-19

09/12/2020 MaP 0

Pfizer Canada and BioNTech SE (Nasdaq: BNTX) today announced that Health Canada has granted Authorization under Interim Order for the emergency use of their mRNA […]

Pfizer and BioNTech Submitted Application for Conditional Marketing Authorization for COVID-19 Vaccine to the EMA

01/12/2020 MaP 0

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) have submitted on Monday, November 30, 2020, a formal Application for Conditional Marketing Authorization (CMA) to […]

Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 Vaccine

20/11/2020 MaP 0

—————————————————————————————————————- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced they will submit a request today to the U.S. Food and Drug Administration (FDA) […]

Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints

18/11/2020 MaP 0

Pfizer and BioNTech plan to submit the efficacy and safety data from the study for peer-review in a scientific journal once analysis of the data […]

Posts navigation

1 2 »

Translation

en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianja Japaneseko Koreanpt Portugueseru Russianes Spanish

Search

Categories

  • Animal health
  • Asthma
  • Cancer
  • COVID-19
  • EIB
  • FCPA Investigations
  • FDA
  • Finance
  • Humanitarian Aid
  • Imprint
  • Influenza
  • MS
  • News
  • Rheumatology
  • Space Science
  • UN
  • Vaccines

Reports

  • Merck Announces Formation of Merck Digital Ethics Advisory Panel
  • Statement regarding European Commission’s Proposal to Purchase Additional Doses of BioNTech-Pfizer Vaccine
  • An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation
  • BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
  • Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics

Archive

  • January 2021 (6)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
  • Merck Announces Formation of Merck Digital Ethics Advisory Panel

    08/01/2021 0
  • Statement regarding European Commission’s Proposal to Purchase Additional Doses of BioNTech-Pfizer Vaccine

    08/01/2021 0
  • An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation

    08/01/2021 0
  • BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science

    07/01/2021 0
  • Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics

    07/01/2021 0
Archives
  • January 2021 (6)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
TAGS
affected africa aid biontech commission companies coronavirus covid-19 covid19 crisis economy elpais.com eu europe european fda fight food global guarantee health hygiene italy links medical merck novartis pandemic pfizer production products recommendations recovery region response roche safety scheme sector spain state statistics stats support vaccine

Copyright © 2021 | WordPress Theme by MH Themes